Literature DB >> 1728182

Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10?

J R Hughes1, A H Oliveto, J E Helzer, S T Higgins, W K Bickel.   

Abstract

OBJECTIVE: The authors reviewed basic science and clinical data on caffeine abuse, dependence, and withdrawal in order to make a conclusion about whether these disorders exist and should be included in DSM-IV and ICD-10.
METHOD: Studies were located through computerized searches, reference sections of published articles, and written requests.
RESULTS: The studies show that abstinence from caffeine induces a withdrawal syndrome of headache, fatigue, and drowsiness which begins within 12-24 hours and lasts about 1 week. The syndrome can be severe and appears to be one reason for continued use of coffee. The prevalence of this caffeine withdrawal syndrome is unknown. Use of caffeine may aggravate some common behavioral and medical disorders. In double-blind tests, a subset of coffee and soda drinkers reliably self-administered caffeinated beverages in preference to uncaffeinated beverages. Clinical indicators of dependence, such as difficulty stopping use of caffeine and use despite harm, have not been documented.
CONCLUSIONS: Caffeine withdrawal but not caffeine abuse or dependence should be included as a diagnosis in DSM-IV and ICD-10. Future research should focus on whether some caffeine users exhibit clinical indicators of drug dependence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728182     DOI: 10.1176/ajp.149.1.33

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  15 in total

Review 1.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

2.  Intralipid in acute caffeine intoxication: a case report.

Authors:  Luisa Muraro; Laura Longo; Federico Geraldini; Andrea Bortot; Andrea Paoli; Annalisa Boscolo
Journal:  J Anesth       Date:  2016-06-07       Impact factor: 2.078

3.  Caffeine Withdrawal and Dependence: A Convenience Survey Among Addiction Professionals.

Authors:  Alan J Budney; Pamela C Brown; Roland R Griffiths; John R Hughes; Laura M Juliano
Journal:  J Caffeine Res       Date:  2013-06

4.  Evaluating Dependence Criteria for Caffeine.

Authors:  Catherine L W Striley; Roland R Griffiths; Linda B Cottler
Journal:  J Caffeine Res       Date:  2011-12

Review 5.  Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics?

Authors:  Andreas Straube; Bernhard Aicher; Bernd L Fiebich; Gunther Haag
Journal:  BMC Neurol       Date:  2011-03-31       Impact factor: 2.474

Review 6.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

7.  Caffeine consumption in hospitalized psychiatric patients.

Authors:  M Rihs; C Muller; P Baumann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 8.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

9.  Caffeine increases liking and consumption of novel-flavored yogurt.

Authors:  Leah M Panek; Christine Swoboda; Ashley Bendlin; Jennifer L Temple
Journal:  Psychopharmacology (Berl)       Date:  2013-01-26       Impact factor: 4.530

Review 10.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.